Buyer Takeaway: Medication verification and storage confirmation are steps you should take personally before your first injection
Patients should be counseled about gastrointestinal side effects and the importance of gradual dose titration
For people managing nausea, early satiety, or busy schedules on GLP-1 therapy, that messaging is understandably appealing
Several studies have reported an inverse relationship between BMI and therapeutic efficacy, indicating that obesity may attenuate clinical responses to biologic disease modifying anti-rheumatic drugs (bDMARDs)
Patients on Semaglutide should have regular follow-ups with our Thrive Medical Spa provider to monitor blood glucose levels, weight, and any potential side effects
GLP-1s and Obesity Coverage: Differing Perspectives for Employers and Health Plans Posted on August 21, 2025 A Snippet From Our GLP-1 Spotlight Webinar Key Points Employers tend to view obesity as a chronic condition, while health plans lean slightly toward viewing obesity as a lifestyle condition